Management of Acute Respiratory Disorders: Utilizing Adjunctive Therapies in a Hospital Care Setting

In this archived Web conference, Michael R. Pinsky, MD, discusses the importance of reducing respiratory distress for patients in an emergency department setting and the use of helium and oxygen mixtures for aerosolized drug delivery and shares his insight and clinical tips that you can readily apply in practice. Although this activity is no longer eligible for CME credit, it remains available on this website as an educational resource.

CME-accredited breakfast satellite symposium

Register now for the CME-accredited breakfast satellite symposium held in conjunction with the American Association of Clinical Endocrinologists' 27th Annual Scientific & Clinical Congress

Outcomes Measurement Initiative Case Studies

The goal of the Outcomes Measurement Initiative (OMI) program is to assess the educational value of the Consortium for Improvement in Erectile Function (CIEF) by receiving feedback on practice patterns from CIEF members. In phase I of the initiative, a comprehensive survey was developed to assess the educational value of the CIEF programs. The second phase consists of 11 case studies developed by CIEF members based on their clinical experience with phosphodiesterase type 5 inhibitors (sildenafil, tadalafil, and vardenafil). Presented in an engaging format, these case studies are available here for use in educational venues.

Recognizing the Heterogeneity of Type 1 Gaucher Disease Symptomatology to Advance Differential Diagnosis Rate

Gregory M. Pastores, MD, using an interactive case study, teaches how to diagnose and manage type 1 Gaucher disease, including pathophysiology and complications. Although this activity is no longer eligible for CME credit, it remains available on this website as an educational resource.

Evolving Paradigm for Mild to Moderate Type 1 Gaucher Disease: Earlier Diagnosis and Treatment Choices

Atul Mehta, MD; Gregory M. Pastores, MD; and Neal J. Weinreb, MD, discuss managing and treating type 1 Gaucher disease in this online monograph. Although this activity is no longer eligible for CME credit, it remains available on this website as an educational resource.

Changing Treatment Paradigms to Optimize Outcomes for Patients With Type 1 Gaucher Disease: A Case-Based Approach

Gregory Pastores, MD (Chairperson); Atul Mehta, MD; and Pilar Giraldo, MD, presented a 1-hour Web conference on managing and treating type 1 Gaucher disease. Although this activity is no longer eligible for CME credit, it remains available on this website as an educational resource.

CME Webcast

Unexpected “Consequences” of HSDD Prescription Treatment: A Post Hoc Analysis

Activity Approved for CME Credit: 1.0 AMA PRA Category 1 Credits™
Release/Expiration dates: April 19, 2018/2019

Clinician’s Tool Case: Decreased Sexual Desire Screener (DSDS)

The HerDesire.net Clinician’s Tool Case is now available. This educational resource features a downloadable Decreased Sexual Desire Screener (DSDS) and an Audio Introduction to the DSDS by Anita H. Clayton, MD, FAPA, IF. The DSDS plays an integral role in assisting clinicians with screening for and accurate diagnosis of HSDD.

Activity Approved for CME Credit: .25 hour - ACCME
Release Date: November 24, 2015
Expiration Date: November 24, 2017

HerDesire: Clinical Position Paper

Activity Approved for CME Credit: 1.0 hour - ACCME, CBRN, AANP
Release Date: April 4, 2014
Expiration Date: April 4, 2016

AAFP Satellite Symposium Webcast

In this CME satellite symposium Webcast titled The Primary Perspective: Bridging Gaps in Male Urologic and Cardiovascular Health, of a live program held in conjunction with AAFP, Culley C. Carson III, MD, and Martin M. Miner, MD, examine strategies to improve the concomitant management of ED, BPH/LUTS, hypogonadism, and CVD with PDE5 inhibitor therapy and testosterone therapy, focusing on how the management of these conditions may improve cardiometabolic parameters and overall health. This educational activity is eligible for a maximum of 1.25 AMA PRA Category 1 Credit(s)^™ through November 20, 2015.

Hypogonadism and Cardiometabolic Disease: Defining the Relationship

View presentations from the CME-certified symposium exploring the relationship between hypogonadism and cardiovascular disease held in conjunction with the American College of Physicians annual meeting, Internal Medicine 2012. Wayne J.G. Hellstrom, MD, serves as Chairperson, and the faculty are Adrian S. Dobs, MD, MHS, and Martin M. Miner, MD.

KOL Video Debate

Four multidisciplinary key opinion leaders debate cutting-edge issues in 6 videos, each highlighting a different aspect of hypogonadism management. Martin M. Miner, MD (primary care), serves as Chairperson, and the faculty are Adrian S. Dobs, MD, MHS (endocrinology); Robert A. Kloner, MD, PhD (cardiology); and Abraham Morgentaler, MD (urology). Although this activity is no longer eligible for CME credit, it remains available on this website as an educational resource.

Newsletter

Adrian S. Dobs, MD, MHS, and John E. Morley, MB, BCh, discuss the relationship between hypogonadism and osteoporosis. Although this activity is no longer eligible for CME credit, it remains available on this website as an educational resource.

Slide Library

This feature allows members to create their own PowerPoint^® presentations online by selecting slides from several modules, including epidemiology, diagnosis and assessment, clinical management and monitoring of the prostate, and current and novel therapeutic options. These slides were specifically developed as a resource for healthcare professionals interested in hypogonadism who need customized presentations for speaking engagements.

Mechanisms and Clinical Targets of Chronic Migraine: Clinical Perspectives and Advancements— A Town Hall Forum

Access materials presented at the CME-certified symposium on the management of chronic migraine held during the 53rd Annual Scientific Meeting of the American Headache Society^®. This educational activity reviews the diagnosis, risk factors, economic burden, and optimal treatment of chronic migraine.

Refractory Idiopathic and Neurogenic Detrusor Overactivity: Case Studies of Localized Treatment Modalities

Access materials presented at the CME-certified symposium exploring the differences between idiopathic and neurogenic overactive bladder (OAB) held in conjunction with the AUA 2011 Annual Meeting. Faculty discussed management and treatment options for refractory OAB (idiopathic and neurogenic).

Educational Effectiveness: Outcomes Evaluation of the NeuroRehab Preceptor Training Program

This CME-certified Outcomes Measurement White Paper reviews the program objectives and educational results of the NeuroRehab Preceptor Program titled Identification and Management of Spasticity and Muscle Overactivity in Upper Motor Neuron Syndrome: A Hands-on Approach. The NeuroRehab Preceptor Program provided a one-on-one and two-on-one forum in which a preceptor (a specialist in treating spasticity, muscle overactivity, and spastic paresis) mentored practicing neurologists and physiatrists and neurology and physiatry residents in a clinical setting. In a ¾-day program, the preceptor reviewed patients with spasticity or other conditions that result from upper motor neuron syndrome with the participating physicians at the physicians’ or preceptor’s office, clinic, or institution. This paper evaluates how the program’s innovative training method impacted physicians’ skills with differential diagnosis, identifying appropriate treatment options, setting goals, and reviewing protocols for various pharmacologic therapies for patients affected with spasticity and muscle overactivity.